196 related articles for article (PubMed ID: 10530985)
21. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
[TBL] [Abstract][Full Text] [Related]
22. [Clinical appearance and outcome of zone 1 retinopathy of prematurity (ROP)].
Odehnal M; Malec J; Hlozánek M; Dotrelová D
Cesk Slov Oftalmol; 2006 Sep; 62(5):316-23. PubMed ID: 17039918
[TBL] [Abstract][Full Text] [Related]
23. [Use of cryotherapy in retinopathy of prematurity].
Starzycka M; Kobylarz J; Starzycka-Bigaj E
Klin Oczna; 1996 Jan; 98(1):33-6. PubMed ID: 9019572
[TBL] [Abstract][Full Text] [Related]
24. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Dobson V; Quinn GE; Summers CG; Saunders RA; Phelps DL; Tung B; Palmer EA
Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4236-44. PubMed ID: 8002243
[TBL] [Abstract][Full Text] [Related]
25. Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.
McGregor ML; Bremer DL; Cole C; McClead RE; Phelps DL; Fellows RR; Oden N;
Pediatrics; 2002 Sep; 110(3):540-4. PubMed ID: 12205257
[TBL] [Abstract][Full Text] [Related]
26. Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization.
Cryotherapy for Retinopathy of Prematurity Cooperative Group
Arch Ophthalmol; 1996 Apr; 114(4):417-24. PubMed ID: 8602778
[TBL] [Abstract][Full Text] [Related]
27. Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial. The CRYO-Retinopathy of Prematurity Cooperative Group.
Quinn GE; Dobson V; Hardy RJ; Tung B; Phelps DL; Palmer EA
Ophthalmology; 1996 Sep; 103(9):1432-7. PubMed ID: 8841302
[TBL] [Abstract][Full Text] [Related]
28. The outcome of cryotherapy for retinopathy of prematurity (ROP) according to ROP location.
Khwarg SI; Yu HG; Yu YS
Korean J Ophthalmol; 1996 Dec; 10(2):92-6. PubMed ID: 9055537
[TBL] [Abstract][Full Text] [Related]
29. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.
Cryotherapy for Retinopathy of Prematurity Cooperative Group
Arch Ophthalmol; 2001 Aug; 119(8):1110-8. PubMed ID: 11483076
[TBL] [Abstract][Full Text] [Related]
30. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group.
Kivlin JD; Biglan AW; Gordon RA; Dobson V; Hardy RA; Palmer EA; Tung B; Gilbert W; Spencer R; Cheng KP; Buckley E
Arch Ophthalmol; 1996 Feb; 114(2):150-4. PubMed ID: 8573016
[TBL] [Abstract][Full Text] [Related]
31. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.
Reynolds JD; Dobson V; Quinn GE; Fielder AR; Palmer EA; Saunders RA; Hardy RJ; Phelps DL; Baker JD; Trese MT; Schaffer D; Tung B;
Arch Ophthalmol; 2002 Nov; 120(11):1470-6. PubMed ID: 12427059
[TBL] [Abstract][Full Text] [Related]
32. The effect of early treatment at the initial stage 3 moderate phase of retinopathy of prematurity on severe retinal changes.
Hatsukawa Y; Ueki N; Yamagishi T; Kitajima H
Jpn J Ophthalmol; 2005; 49(5):391-6. PubMed ID: 16187040
[TBL] [Abstract][Full Text] [Related]
33. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].
Huang ZN; Yin DM; Huang DR; Liang SX
Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127
[TBL] [Abstract][Full Text] [Related]
34. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.
Good WV;
Trans Am Ophthalmol Soc; 2004; 102():233-48; discussion 248-50. PubMed ID: 15747762
[TBL] [Abstract][Full Text] [Related]
35. The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Arch Ophthalmol; 1994 Jul; 112(7):903-12. PubMed ID: 8031269
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Quinn GE; Dobson V; Kivlin J; Kaufman LM; Repka MX; Reynolds JD; Gordon RA; Hardy RJ; Tung B; Stone RA
Ophthalmology; 1998 Jul; 105(7):1292-300. PubMed ID: 9663236
[TBL] [Abstract][Full Text] [Related]
37. Management outcome in prethreshold retinopathy of prematurity.
Azad RV; Sethi A; Kumar H
J Pediatr Ophthalmol Strabismus; 2003; 40(6):330-4. PubMed ID: 14655980
[TBL] [Abstract][Full Text] [Related]
38. The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams. Results through 5 1/2 years. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Repka MX; Summers CG; Palmer EA; Dobson V; Tung B; Davis B
Ophthalmology; 1998 Sep; 105(9):1621-7. PubMed ID: 9754167
[TBL] [Abstract][Full Text] [Related]
39. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Palmer EA; Flynn JT; Hardy RJ; Phelps DL; Phillips CL; Schaffer DB; Tung B
Ophthalmology; 1991 Nov; 98(11):1628-40. PubMed ID: 1800923
[TBL] [Abstract][Full Text] [Related]
40. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.
Palmer EA; Hardy RJ; Dobson V; Phelps DL; Quinn GE; Summers CG; Krom CP; Tung B;
Arch Ophthalmol; 2005 Mar; 123(3):311-8. PubMed ID: 15767472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
